• About CCSB
  • |
  • News
  • |
  • Contact Us
  • |
  • Site Map
  •  
  •   中文版
CCSB's
  • ESG
  • Investor Relations
  • Events
  • Contract Research
  • Contract Manufacturing
  • API Products
CCBS NEWS

CCBS NEWS

News
Download
Contact Us
search

News

Home > News > News
news title
  • 2024/01/25CCSB accomplished Caspofungin audit.
  • 2024/01/11CCSB obtained US patent for Tofacitinib Citrate
  • 2023/01/17CCSB obtained US patent for Etelcalcetide
  • 2023/01/12CCSB accomplished Trandolapril audit.
  • 2022/12/20CCSB accomplished Methocarbamol remote audit.
  • 2022/11/18CCSB accomplished an inspection of The Food and Drug Administration (USFDA).
  • 2022/10/12CCSB accomplished Rapamycin remote audit
  • 2022/09/21CCSB accomplished Tacrolimus remote audit.
  • 2022/09/16CCSB accomplished EVE and Rapamycin remote audit.
  • 2022/08/04CCSB accomplished Sugammadex Sodiumaudit.
 Prev 1  2  3  4  5  6  7  8  9  10 Next  
© Chunghwa Chemical Synthesis & Biotech Co. Ltd. All right reserved.